Protocol to Practice: Understanding the Statewide Protocol 2025 Update for Pharmacist-Initiated Human Immunodeficiency Virus (HIV) Post-Exposure Prophylaxis (PEP)
Speaker Information
Ty Chapman, PharmD
Executive Fellow
NC Association of Pharmacists
Learning Objectives:
Describe the legislative origins and policy development of pharmacist-initiated HIV post-exposure prophylaxis (PEP) in North Carolina
Analyze and compare HIV epidemiological trends in the US and NC to identify population-specific needs and disparities
Summarize key updates from the 2025 CDC recommendations for antiretroviral (ARV) PEP after sexual, injection drug use, or other nonoccupational exposures to HIV
Interpret and differentiate major components of the 2025 NC Board of Pharmacy (NCBOP) and NC Board of Medicine (NCBOM) statewide protocol for pharmacist-initiated PEP for HIV
Implement pharmacist-initiated PEP services through case-based applications that integrate assessment, prescribing, counseling, and documentation practices in NC pharmacy settings
Description:
Pharmacists are on the front lines of HIV prevention — and North Carolina’s updated 2025 statewide protocol empowers them like never before. This session will explore the evolution and impact of pharmacist-initiated HIV post-exposure prophylaxis (PEP), highlighting new CDC and NC Board of Pharmacy and Medicine's guidance. Attendees will gain actionable tools to confidently assess patient eligibility, initiate treatment, and integrate PEP into community pharmacy workflows. Join us to stay ahead of the curve in expanding equitable access to HIV prevention and strengthening public health across our state.
